StockData
AnaptysBio, Inc logo

AnaptysBio, Inc (ANAB) stock

ANABNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 9/30
$49.24+2.63 (+5.64%)

Close on Oct 19, 2026Market cap $2.28BP/E –Yield –

AnaptysBio revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

AnaptysBio's revenue for the twelve months ending Jun 30, 2026 was $237.61M, up 92.9% year over year. For fiscal 2025 it was $234.60M, up 157.0% from the year before. Over ten years it grew 29.6% a year on average. The highest annual figure on record is $234.60M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$234.60M+157.0%
FY2024Dec 31, 2024$91.28M+432.0%
FY2023Dec 31, 2023$17.16M+66.8%
FY2022Dec 31, 2022$10.29M-83.7%
FY2021Dec 31, 2021$63.18M-15.8%
FY2020Dec 31, 2020$75.00M+837.5%
FY2019Dec 31, 2019$8.00M+60.0%
FY2018Dec 31, 2018$5.00M-50.0%
FY2017Dec 31, 2017$10.00M-40.1%
FY2016Dec 31, 2016$16.68M-5.0%
FY2015Dec 31, 2015$17.57M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$27.49M+23.5%
Q1 FY2026Mar 31, 2026$25.56M-8.0%
Q4 FY2025Dec 31, 2025$108.25M+151.1%
Q3 FY2025Sep 30, 2025$76.32M+154.3%
Q2 FY2025Jun 30, 2025$22.26M+102.9%
Q1 FY2025Mar 31, 2025$27.77M+286.8%
Q4 FY2024Dec 31, 2024$43.11M+378.8%
Q3 FY2024Sep 30, 2024$30.02M+804.7%
Q2 FY2024Jun 30, 2024$10.97M+217.1%
Q1 FY2024Mar 31, 2024$7.18M+422.5%
Q4 FY2023Dec 31, 2023$9.01M+32.3%
Q3 FY2023Sep 30, 2023$3.32M+156.6%
Q2 FY2023Jun 30, 2023$3.46M+184.5%
Q1 FY2023Mar 31, 2023$1.37M+41.6%
Q4 FY2022Dec 31, 2022$6.81M+573.4%
Q3 FY2022Sep 30, 2022$1.29M-93.8%
Q2 FY2022Jun 30, 2022$1.22M-96.0%
Q1 FY2022Mar 31, 2022$970.00K-91.4%
Q4 FY2021Dec 31, 2021$1.01M-98.3%
Q3 FY2021Sep 30, 2021$20.89M–
Q2 FY2021Jun 30, 2021$30.03M–
Q1 FY2021Mar 31, 2021$11.25M-25.0%
Q4 FY2020Dec 31, 2020$60.00M+1900.0%
Q3 FY2020Sep 30, 2020$0–
Q2 FY2020Jun 30, 2020$0-100.0%
Q1 FY2020Mar 31, 2020$15.00M–
Q4 FY2019Dec 31, 2019$3.00M–
Q3 FY2019Sep 30, 2019$0-100.0%
Q2 FY2019Jun 30, 2019$5.00M–
Q1 FY2019Mar 31, 2019$0–
Q4 FY2018Dec 31, 2018$0-100.0%
Q3 FY2018Sep 30, 2018$5.00M–
Q2 FY2018Jun 30, 2018$0-100.0%
Q1 FY2018Mar 31, 2018$0–
Q4 FY2017Dec 31, 2017$3.00M+8.9%
Q3 FY2017Sep 30, 2017$0-100.0%
Q2 FY2017Jun 30, 2017$7.00M–
Q1 FY2017Mar 31, 2017$0–
Q4 FY2016Dec 31, 2016$2.75M–
Q3 FY2016Sep 30, 2016$3.21M–

More AnaptysBio figures

See a number that looks wrong?